Delivery Order SPE2DX22D0010-SPE2D825FJM87
- Not listed
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on September 18, 2025, for the supply of Adzenys XR-ODT 18.8 mg tablets (30-unit dose packages) at a ceiling value of $1,022.24. The contract is classified as a firm fixed-price delivery order with an ultimate completion date of September 19, 2025, and carries no set-aside designation, indicating it was awarded through open competition. This delivery order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Adzenys XR-ODT 3.1 mg tablets in unit dose packaging (30-count) with a ceiling value of $2,063.20. This is a firm fixed-price delivery order with an ultimate completion date of July 30, 2025, and represents a non-set-aside procurement awarded through competitive bidding. The order will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania. This delivery...
- AmerisourceBergen Drug Corp, a leading pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,521.90 by the Defense Logistics Agency's Medical Supply Chain on August 4, 2025, with an ultimate completion date of August 5, 2025. The delivery order, issued under a firm fixed price contract type, covers the supply of ADZENYS XR ODT Tablets 1's 6.3MG, a prescription medication used in the treatment of attention-deficit/hyperactivity disorder....
- This is a firm fixed-price delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,770.93 contract is for the supply of ADZENYS XR-ODT 18.8 MG TABLET UD 30S, a pharmaceutical product, with a period of performance through May 1, 2025. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
- The Defense Logistics Agency Medical Supply Chain awarded a $1,722.72 delivery order to AmerisourceBergen Drug Corp for ADZENYS XR 12.5MG tablets (30-count) on June 20, 2025, with an ultimate completion date of June 23, 2025. This firm fixed-price, non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion vehicle valued through December 2026. The order will be fulfilled from...
- The Defense Logistics Agency awarded a firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Adzenys XR-ODT 18.8 mg tablets in unit-dose packaging of 30 units, with a ceiling value of $1,927.41. The contract was awarded on August 13, 2025, with an ultimate completion date of August 14, 2025, and represents a non-set-aside, competitively awarded transaction. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- This is a $1,119.16 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of ADZENYS XR-ODT 6.3 MG TABLET UD 30S, a prescription medication, with a completion date of February 25, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing...
- This delivery order, awarded on August 18, 2025, represents a competitively awarded, firm fixed-price contract for pharmaceutical supplies valued at $9,107.57. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was selected to supply Adzenys XR ODT tablets (1's, 18.8mg), a medication used in the treatment of attention-deficit/hyperactivity disorder. The contract is classified as a non-set-aside award and carries an ultimate completion...
- This is a $1,642.02 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of ADZENYS XR-ODT 3.1 MG TABLET UD 30S, a pharmaceutical product. The contract has an ultimate completion date of January 21, 2025 and was awarded on January 17, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,594.19 firm fixed price delivery order is for the supply of ADZENYS XR ODT TABS 1'S 3.1MG, a prescription medication. The contract has an ultimate completion date of August 6, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999 through...
- SPE2DX22D0010Indefinite Delivery Contract
- SPE2DX22D0010-SPE2D825FJM87Delivery Order
The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 19, 2025, for supply of ADZENYS XR ODT tablets (amphetamine extended-release orally disintegrating tablets) at a ceiling value of $1,968.19. This is a firm fixed-price delivery order with no set-aside designation, representing a competitive award under AmerisourceBergen's existing pharmaceutical supply contract. The order is scheduled for completion by September 22, 2025, with performance at the contractor's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The IDC serves as a global pharmaceutical support vehicle enabling AmerisourceBergen to supply a comprehensive range of brand-name and generic medications, vaccines, and medical supplies to support military healthcare programs worldwide. As a major pharmaceutical distributor and critical federal vendor, AmerisourceBergen fulfills orders across multiple therapeutic domains for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.0k | 9/19/25 |